Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Spectroscopy,Pollution,Radiology Nuclear Medicine and imaging,Nuclear Energy and Engineering,Analytical Chemistry
Reference14 articles.
1. Decristoforo C, Mather SJ (1999) Preparation, 99mTc labeling and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]-octreotide. Bioconjug Chem 10(3):431–438
2. Decristoforo C, Mather SJ, Cholewinski W, Donnemiller E, Riccabona G, Moncayo R (2000) 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives. Eur J Nucl Med 27(9):1318–1325
3. Decristoforo C, Melendez-Alafort L, Sosabowski JK, Mather SJ (2000) 99mTc-HYNIC-[Tyr3]-octreotumors: preclinical evaluation and comparison with 111In-octreotide. J Nucl Med 41:1114–1119
4. Eising EG, Bier D, Knust EJ, Reieners C (1996) Somatostatin receptor scintigraphy, methodogy, indications, results. Radiologe 36:81
5. Gabriel M, Decristoforo C, Donnemiller E, Ulmer H, Watfah Rychlinski C, Mather SJ, Moncayo R (2003) An intrapatient comparison of 99mTc-EDDA-HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor expressing tumors. J Nucl Med 44(5):708–716
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献